Dr Mark A Petroff, MD | |
17720 Jean Way, Suite100, Lake Oswego, OR 97035-5394 | |
(503) 635-4886 | |
(503) 635-1655 |
Full Name | Dr Mark A Petroff |
---|---|
Gender | Male |
Speciality | Plastic Surgery - Plastic Surgery Within The Head And Neck |
Location | 17720 Jean Way, Lake Oswego, Oregon |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528068129 | NPI | - | NPPES |
MD15996 | Other | OR | STATE LICENSE |
069609 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2082S0099X | Plastic Surgery - Plastic Surgery Within The Head And Neck | MD15996 (Oregon) | Primary |
Entity Name | Mark A Petroff Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144365941 PECOS PAC ID: 5890709059 Enrollment ID: O20060127000028 |
News Archive
Researchers have invented a technique that uses inexpensive paper to make "microfluidic" devices for rapid medical diagnostics and chemical analysis.
The U.S. Food and Drug Administration today warned that the unapproved use of the malaria drug Qualaquin (quinine sulfate) to treat night time leg cramps has resulted in serious side effects and prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks.
A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.
Enobia Pharma announced today the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six-month study will assess the safety, efficacy and pharmacokinetics of ENB-0040 in up to 12 children with HPP.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mark A Petroff, MD 17720 Jean Way, Suite100, Lake Oswego, OR 97035-5394 Ph: (503) 635-4886 | Dr Mark A Petroff, MD 17720 Jean Way, Suite100, Lake Oswego, OR 97035-5394 Ph: (503) 635-4886 |
News Archive
Researchers have invented a technique that uses inexpensive paper to make "microfluidic" devices for rapid medical diagnostics and chemical analysis.
The U.S. Food and Drug Administration today warned that the unapproved use of the malaria drug Qualaquin (quinine sulfate) to treat night time leg cramps has resulted in serious side effects and prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks.
A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.
Enobia Pharma announced today the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six-month study will assess the safety, efficacy and pharmacokinetics of ENB-0040 in up to 12 children with HPP.
› Verified 6 days ago
Dr. Elisa A Burgess, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 16865 Boones Ferry Rd, Suite 101, Lake Oswego, OR 97035 Phone: 503-699-6464 Fax: 503-699-6939 | |
Dr. Tuan Anh Nguyen, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 15820 Quarry Rd, Lake Oswego, OR 97035 Phone: 503-635-1955 Fax: 503-635-1958 |